E-cigarettes, promoted as a way to quit regular cigarettes, may actually be a new route to conventional smoking and nicotine addiction for teenagers, according to a new UCSF study.
March 05, 2014
UCSF neuroscientist Adam Gazzaley, MD, PhD, is hoping to paint a fuller picture of what is happening in the minds and bodies of those suffering from brain disease with his new lab, Neuroscape, which bridges the worlds of neuroscience and high-tech.
March 04, 2014
A new UCSF study has shed light on the origins of one type of deadly pancreatic cancer, which could lead to more targeted and effective drug therapy.
February 26, 2014
Over the past 18 months, physicians in California have observed on rare occasions what may be a new disease, one in which patients, usually children, quickly and permanently lose muscle function in an arm or leg.
February 26, 2014
Researchers worldwide will now have access to genetic data linked to medical information on a diverse group of more than 78,000 people, enabling investigations into many diseases and conditions.
February 25, 2014
UCSF and Walgreens have opened a unique Walgreens store that aims to improve medication safety, decrease health care costs and help patients use medicines more effectively.
February 23, 2014
Scientists at the Gladstone Institutes and UCSF have made an important breakthrough: they have discovered a way to transform skin cells into mature, fully functioning liver cells that flourish.
February 21, 2014
Samsung Electronics Co., Ltd., and UC San Francisco have announced a partnership to accelerate validation and commercialization of promising new sensors, algorithms, and digital health technologies for preventive health solutions.
February 20, 2014
Scientists at the UCSF-affiliated Gladstone Institutes have devised a new method that allows for the more efficient and complete reprogramming of skin cells into cells that are virtually indistinguishable from heart muscle cells.
February 19, 2014
Genetic testing can help doctors choose the most effective and economical drugs to prevent blood clots in the half a million patients in the U.S. who receive coronary stents each year, according to a new study led by a UCSF researcher.